 D61 |
 |
Other aplastic anemias and other bone marrow failure syndromes  |
| |
| Excludes2 |
neutropenia (D70.-)
|
|
| |
| D61.0 |
|
Constitutional aplastic anemia |
| |
 D61.01 |
|
Constitutional (pure) red blood cell aplasia |
| |
| Blackfan-Diamond syndrome | | Congenital (pure) red cell aplasia | | Familial hypoplastic anemia | | Primary (pure) red cell aplasia | | Red cell (pure) aplasia of infants |
| Excludes1 |
acquired red cell aplasia (D60.9)
|
|
| | |
| D61.02 |
|
Shwachman-Diamond syndrome |
| |
| CodeAlso |
, if applicable, associated conditions such as:
acute myeloblastic leukemia (C92.0-)
exocrine pancreatic insufficiency (K86.81)
myelodysplastic syndrome (D46.-)
|
| UseAdditionalCode |
code, if applicable, for genetic susceptibility to other malignant neoplasm (Z15.09)
|
|
| | |
| D61.03 |
|
Fanconi anemia |
| |
| Fanconi pancytopenia | | Fanconi's anemia |
| Excludes1 |
Fanconi syndrome (E72.0-)
|
|
| | |
| D61.09 |
|
Other constitutional aplastic anemia |
| |
| Pancytopenia with malformations |
|
| |
| |
| D61.1 |
|
Drug-induced aplastic anemia |
| |
| UseAdditionalCode |
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
|
|
|
| |
| D61.2 |
|
Aplastic anemia due to other external agents |
| |
| CodeFirst |
, if applicable, toxic effects of substances chiefly nonmedicinal as to source (T51-T65)
|
|
|
| |
| D61.3 |
|
Idiopathic aplastic anemia |
|
| |
| D61.8 |
|
Other specified aplastic anemias and other bone marrow failure syndromes |
| |
| D61.81 |
|
Pancytopenia |
| |
| Excludes1 |
pancytopenia (due to) (with) aplastic anemia (D61.9)
pancytopenia (due to) (with) bone marrow infiltration (D61.82)
pancytopenia (due to) (with) congenital (pure) red cell aplasia (D61.01)
pancytopenia (due to) (with) hairy cell leukemia (C91.4-)
pancytopenia (due to) (with) human immunodeficiency virus disease (B20.-)
pancytopenia (due to) (with) leukoerythroblastic anemia (D61.82)
pancytopenia (due to) (with) myeloproliferative disease (D47.1)
|
| Excludes2 |
pancytopenia (due to) (with) myelodysplastic syndromes (D46.-)
|
|
| |
| D61.810 |
|
Antineoplastic chemotherapy induced pancytopenia |
| |
| Excludes2 |
aplastic anemia due to antineoplastic chemotherapy (D61.1)
|
|
| | |
| D61.811 |
|
Other drug-induced pancytopenia |
| |
| Excludes2 |
aplastic anemia due to drugs (D61.1)
|
|
| | |
| D61.818 |
|
Other pancytopenia |
| | | |
| D61.82 |
|
Myelophthisis |
| |
| Leukoerythroblastic anemia | | Myelophthisic anemia | | Panmyelophthisis |
| CodeAlso |
the underlying disorder, such as:
malignant neoplasm of breast (C50.-)
tuberculosis (A15.-)
|
| Excludes1 |
idiopathic myelofibrosis (D47.1)
myelofibrosis NOS (D75.81)
myelofibrosis with myeloid metaplasia (D47.4)
primary myelofibrosis (D47.1)
secondary myelofibrosis (D75.81)
|
|
| | |
| D61.89 |
|
Other specified aplastic anemias and other bone marrow failure syndromes |
| |
| |
| D61.9 |
|
Aplastic anemia, unspecified |
| |
| Hypoplastic anemia NOS | | Medullary hypoplasia |
|
|